| Schedule of Earnings Per Share |
The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended July 31, | | Six Months Ended July 31, | | | 2025 | | 2024 | | 2025 | | 2024 | | Numerator: | | | | | | | | | Net loss attributable to common stockholders | $ | (22,592) | | | $ | (38,668) | | | $ | (35,220) | | | $ | (67,961) | | | Denominator: | | | | | | | | | Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders | 304,129,204 | | 290,364,319 | | 302,230,578 | | 289,328,033 | | Basic and diluted net loss per share attributable to common stockholders | $ | (0.07) | | | $ | (0.13) | | | $ | (0.12) | | | $ | (0.23) | |
|
| Schedule of Antidilutive Securities |
The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: | | | | | | | | | | | | | | As of July 31, | | | 2025 | | 2024 | | Warrants to purchase Class A common stock | 1,065,594 | | 1,065,594 | | Common stock options | 20,264,044 | | 26,106,458 | | Restricted Stock Units | 35,149,035 | | 43,651,697 | | Performance vesting Restricted Stock Units | 194,831 | | 333,771 | | Shares committed under ESPP | 353,206 | | 300,496 | | Earn-out Shares | 24,241,220 | | 24,637,325 | | dMY Sponsor Earn-out Shares | 862,500 | | 862,500 | | Public Warrants | 8,395,715 | | 6,899,982 | | Private Placement Warrants | 4,437,600 | | 5,933,333 | | Early exercised common stock options, subject to future vesting | 367,640 | | 735,280 | | Total | 95,331,385 | | 110,526,436 |
|